Pall Corporation Magnifies Focus on Instrumentation with Expansion of Menlo Park Facility

  Pall Corporation Magnifies Focus on Instrumentation with Expansion of Menlo
  Park Facility

California Center of Excellence to Become Design Authority for Pall
Instrumentation Development

Business Wire

PORT WASHINGTON, N.Y. -- January 10, 2013

Pall Corporation (NYSE:PLL), a global leader in filtration, separation and
purification, today announced that it has expanded its Menlo Park, California
facility, the site of its ForteBio® operations, to create a Center of
Excellence (COE) for Instrumentation. The expanded COE, located in the heart
of the Silicon Valley/Bay area, occupies more than 42,000 sq. feet on two
floors, which is nearly double the size of the original facility. The
multi-disciplinary center handles a broad range of functions from instrument
and consumable reagent manufacturing to product development. Acquired by Pall
in 2012, ForteBio is a division of Pall Life Sciences.

“Process instrumentation represents an important growth market for Pall,” said
Yves Baratelli, president, Pall Life Sciences. “By creating a center that
focuses on instrumentation and process monitoring system design and
development, we are now better positioned to meet the evolving needs of our
research and drug development customers worldwide. The location of the new COE
also will allow us to capitalize on emerging opportunities in strategic local
areas such as the Silicon Valley region.”

To further demonstrate Pall’s commitment to meeting the widening range of
analytical, testing and monitoring needs of its customers, Pall doubled its
Menlo Park facility’s engineering staff and now operates its Global
Instrumentation Field Service Group from the site. Having the field service,
design engineering and manufacturing teams housed at the same facility will
enable Pall to build greater serviceability into its solutions. The facility
also offers customer training.

ForteBio’s flagship Octet® instrumentation platform and related consumable
reagents, as well as the revolutionary smaller scale BLItz™ system, continue
to be manufactured at the Menlo Park facility. The BLItz system enables
scientists to easily and cost-effectively conduct label-free analyses of
proteins using small sample volumes right at their lab bench.

Additional activities being performed at the site include manufacturing of the
Pall® Micro-24 MicroReactor process development system for cell culture and
leading-edge software development related to Pall’s GeneDisc® pathogen
detection platform.

While the current focus of the COE is on life sciences applications, Pall
plans to make the COE an authority on all Pall instrumentation design and
development opportunities.

About Pall Life Sciences

Pall Life Sciences provides cutting-edge products and services to meet the
demanding needs of customers discovering, developing and producing biotech
drugs, vaccines and classic pharmaceuticals. Pall’s membranes and membrane
devices optimize detection and sample preparation in the drug research,
clinical diagnostics, genomics, and proteomics markets. Pall is a leading
provider of separation systems and single-use filtration and purification
technologies to pharmaceutical and biotechnology companies to support faster
development of new drugs and vaccines that are safer and require less energy
and water to produce. Pall technologies are also used in clinical institutions
and the food and beverage industries.

About Pall Corporation
Pall Corporation (NYSE:PLL) is a filtration, separation and purification
leader providing solutions to meet the critical fluid management needs of
customers across the broad spectrum of life sciences and industry. Pall works
with customers to advance health, safety and environmentally responsible
technologies. The company’s engineered products enable process and product
innovation and minimize emissions and waste. Pall Corporation is an S&P 500
company serving customers worldwide. Pall has been named a “top green company”
by Newsweek magazine. To see how Pall is helping enable a greener, safer, more
sustainable future, follow us on Twitter @PallCorporation or visit


Doug Novarro
Pall Corporation
Corporate Public Relations
Follow us on Twitter @pallcorporation
Press spacebar to pause and continue. Press esc to stop.